APA

Miller L. M., Mayer S. C., Berger D. M., Boschelli D. H., Boschelli F., Di L., Du X., Dutia M., Floyd M. B., Johnson M., Kenny C. H., Krishnamurthy G., Moy F., Petusky S., Tkach D., Torres N., Wu B. & Xu W. (20090128). Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. : Bioorganic & medicinal chemistry letters.

Chicago

Miller Lori M, Mayer Scott C, Berger Dan M, Boschelli Diane H, Boschelli Frank, Di Li, Du Xuemei, Dutia Minu, Floyd Middleton B, Johnson Mark, Kenny Cynthia Hess, Krishnamurthy Girija, Moy Franklin, Petusky Susan, Tkach Diane, Torres Nancy, Wu Biqi and Xu Weixin. 20090128. Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. : Bioorganic & medicinal chemistry letters.

Harvard

Miller L. M., Mayer S. C., Berger D. M., Boschelli D. H., Boschelli F., Di L., Du X., Dutia M., Floyd M. B., Johnson M., Kenny C. H., Krishnamurthy G., Moy F., Petusky S., Tkach D., Torres N., Wu B. and Xu W. (20090128). Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. : Bioorganic & medicinal chemistry letters.

MLA

Miller Lori M, Mayer Scott C, Berger Dan M, Boschelli Diane H, Boschelli Frank, Di Li, Du Xuemei, Dutia Minu, Floyd Middleton B, Johnson Mark, Kenny Cynthia Hess, Krishnamurthy Girija, Moy Franklin, Petusky Susan, Tkach Diane, Torres Nancy, Wu Biqi and Xu Weixin. Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. : Bioorganic & medicinal chemistry letters. 20090128.